TechnoBusiness-Solutions.com
Where Powerful Methods Originate and Produce Breakthrough Results

 

How to Develop a Red Hot Prospectus;Invention Brokers;Royalties;New Ventures;Licensing;Commericalization;Medica l devices;pharmaceuticals;consultants

 

idea_bulbhandshkmoney

 

medical device consultants,pharmaceutical consultants,biomedical,diagnosticsSearch Our Website


Step 6. It is now time to develop a  prospectus . It is required for raising the necessary funds to build the prototype parts, order soft tooling, test equipment, etc. 

The prospectus is essentially a well written business plan. Unless you are proficient at this activity, you should definitely hire someone to do it. A poorly written plan would generate for you absolutely no money. So make sure your business plan has a powerful punch in attracting potential investors. 

We list here the essential elements of a prospectus for an initial public offering (IPO.) So if your company has not yet reached that stage, just develop the necessary data per the level of your business. 

Executive Summary

Risk Factors Early Stage of Development and Commercialization; Limited Relevant Operating History | Limited Revenues; History of Losses 

Anticipated Future Losses | Reliance on Development of New Products and Obtaining Regulatory Clearances to Market Existing Products in the primary country market | Government Regulation 

Product Approvals Uncertain | Market Acceptance Uncertain | No Assurance of Clinical Advantages (if it is a medical, pharmaceutical product) | Patient Population Estimates Uncertain (if required) | Reliance on International Sales | Limited Sales and Marketing Capability 

Dependence on Distributors | Highly Competitive Markets ( this is true for almost all businesses today) | Risk of Technological Obsolescence | Dependence on Patents and Proprietary Technology | Ongoing Royalty Obligation (if it is applicable) | Limited Manufacturing Experience | Dependence on Management and Other Key Personnel | Product Liability Risk 

Insurance (if it is applicable) | Uncertainty of Government Health Care Policy and Third-Party Reimbursement (if applicable) | Control by Officers, directors and Principal Stockholders | Future Additional Capital Requirements 

No Assurance Future Capital Will Be Available | Shares Eligible for Future Sale | No Prior Public Market for Common Stock 

Potential Volatility of Stock Price | Absence of Dividends 

Dilution (if this is the case) | Possible Issuances of Preferred Stock 

Anti-Takeover Effect of Certain Bylaw and Statutory Provisions 

Use of Proceeds

Dividend Policy 

Capitalization 

Dilution 

Selected Consolidated Financial Data

Management Discussion and Analysis of Financial Condition and Results of Operations 

Overview, Results of Operations, Liquidity and Capital Resources 

Business

Overview, Strategy, Technology, Products, Distribution, Sales and Marketing, Patents and Proprietary Rights, Competition, Manufacturing, Government Regulation, Third-Party Reimbursement, Employees, Legal Proceedings, Product Liability and Insurance, Facilities 

Management

Directors, Executive Officers and Senior Management, Board of Directors, Executive Compensation, Compensation Committee Interlocks and Insider Participation, Stock option Plans 

Important Company Transactions

Principal Stockholders

Description of Capital Stock

Common Stock, Undesignated Preferred Stock, State Law and Certain Provisions of the Bylaws, Limitations on Liability of Officers and Directors, Shares Eligible for Future Public Sale, Transfer Agent 

Underwriting

Legal Matters 

Experts 

Accounting Firm 

Additional Information 

Index to Consolidated Financial Statements

Report of Independent Accountants 

Consolidated Balance Sheets of Company 

Consolidated Statements of Operations 

Consolidated Statements of Stockholders' Equity 

Consolidated Statements of Cash Flows 

Notes to Consolidated Financial Statements 

The prospectus should be written having in mind the type of individuals to which is going to be presented. A strategy also has to be developed for reaching the desired group of potential investors. Again, unless you know what you are doing, you should hire someone expert to do this for you. 

Note: Any mailed materials to us will not be returned unless you a) clearly specify so and b) provide us with sufficient funds via a money order to cover the shipping and handling expenses. 

help02Click here for all links at this Web Site.

.

back_to_topReturn to the top of this page.

 .

 

Copyright © 1996 TechnoBusiness Solutions(tm). All Rights Reserved.  Disclaimer . Please report questions, problems here

Home
Who We Are
Unique Strengths
Our Services
Projects Resume
Your Next Step
Write Us
What's New
Articles
Ask SolvWizSM For FREE 

TechnoBusiness Solutions
403 Christie Ct., Stewartsville, NJ 08886 USA
Costas B. Chantzis, CEO 


Tel.: 908.387.9276
Fax: 908.387.0447  Email
Home
 
 
 



Home
Who We Are
Unique Strengths
Our Services
Projects Resume
Your Next Step
Write Us
What's New
Articles
Ask SolvWizSM For FREE 

TechnoBusiness Solutions
403 Christie Ct., Stewartsville, NJ 08886 USA
Costas B. Chantzis, CEO 


Tel.: 908.387.9276
Fax: 908.387.0447  Email
Home
 
 
 
 



Home
Who We Are
Unique Strengths
Our Services
Projects Resume
Your Next Step
Write Us
What's New
Articles
Ask SolvWizSM For FREE 

TechnoBusiness Solutions
403 Christie Ct., Stewartsville, NJ 08886 USA
Costas B. Chantzis, CEO 


Tel.: 908.387.9276
Fax: 908.387.0447  Email
Home
 
 

Home
Who We Are
Unique Strengths
Our Services
Projects Resume
Your Next Step
Write Us
What's New
Articles
Ask SolvWizSM For FREE 

TechnoBusiness Solutions
403 Christie Ct., Stewartsville, NJ 08886 USA
Costas B. Chantzis, CEO 


Tel.: 908.387.9276
Fax: 908.387.0447  Email
Home
 
 
 



Home
Who We Are
Unique Strengths
Our Services
Projects Resume
Your Next Step
Write Us
What's New
Articles
Ask SolvWizSM For FREE 

TechnoBusiness Solutions
403 Christie Ct., Stewartsville, NJ 08886 USA
Costas B. Chantzis, CEO 


Tel.: 908.387.9276
Fax: 908.387.0447  Email
Home